OptiNose, Inc. (OPTN)
NASDAQ: OPTN · Real-Time Price · USD
9.28
+0.10 (1.09%)
Apr 24, 2025, 4:00 PM EDT - Market closed
OptiNose Employees
As of December 31, 2024, OptiNose had 128 total employees, including 127 full-time and 1 part-time employees. The number of employees decreased by 4 or -3.03% compared to the previous year.
Employees
128
Change (1Y)
-4
Growth (1Y)
-3.03%
Revenue / Employee
$611,141
Profits / Employee
-$168,289
Market Cap
93.98M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
OPTN News
- 4 weeks ago - OPTINOSE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of OptiNose, Inc. - OPTN - Business Wire
- 4 weeks ago - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BECN and OPTN on Behalf of Shareholders - GlobeNewsWire
- 5 weeks ago - Optinose Cancels Fourth Quarter and Full Year 2024 Earnings Call - GlobeNewsWire
- 5 weeks ago - Paratek Pharmaceuticals to Acquire Optinose, Creating Significant Commercial Expansion Opportunities for XHANCE® in Chronic Rhinosinusitis (CRS) - GlobeNewsWire
- 3 months ago - Optinose Announces Preliminary Unaudited Fourth Quarter 2024 XHANCE Net Revenue of $22.4 Million - GlobeNewsWire
- 4 months ago - Optinose Announces 1-for-15 Reverse Stock Split - GlobeNewsWire
- 5 months ago - Optinose to Present at the Piper Sandler 36th Annual Healthcare Conference - GlobeNewsWire
- 5 months ago - OptiNose, Inc. (OPTN) Q3 2024 Earnings Call Transcript - Seeking Alpha